Spiegel Robert J.
SEC-identified person · CIK 1492256 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Geron Corp GERN | Director | filed 2010–2026 |
| Renovorx, Inc. RNXT | Director | filed 2023–2025 |
| Xcyte Therapies INC XYCT | Director | filed 2018–2023 |
| Athenex, Inc. ATNX | Director | filed 2020–2023 |
| Ayala Pharmaceuticals, Inc. ADXS | Director | filed 2023–2023 |
| Old Ayala, Inc AYLA | Director | filed 2020–2023 |
| PDS Biotechnology Corp PDSB | Director | filed 2015–2019 |
| Sucampo Pharmaceuticals, Inc. SCMP | Director | filed 2015–2018 |
| PTC Therapeutics, INC. PTCT | Chief Medical Officer | filed 2014–2016 |
| Talon Therapeutics, Inc. TLON.OB | Director | filed 2010–2013 |
| Orthologic Corp OLGC | Director | filed 2010–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.